Biosynex SA (ALBIO) Stock Statistics & Valuation Metrics

Biosynex SA has a market cap or net worth of €23.28M. The enterprise value is €81.00M.

Biosynex SA has 18,748,032 shares outstanding. The number of shares has decreased by -2.65% in one year.

Biosynex SA’s return on equity (ROE) is -0.30 and return on invested capital (ROIC) is -16.91%.

The current PE Ratio of Biosynex SA is -2.42. Biosynex SA’s PEG ratio is 0.07.

In the last 12 months, Biosynex SA had revenue of 92.98M and earned -36.95M in profits. Earnings per share was -3.45.

In the last 12 months, operating cash flow was -10.92M and capital expenditures -9.64M, giving a free cash flow of -20.56M billion.

Biosynex SA pays an annual dividend of €2, resulting in a dividend yield of ―

Biosynex SA upcoming earnings date is ―, TBA Not Confirmed.

Biosynex SA as a current ratio of 2.24, with Debt / Equity ratio of 61.05%

In the past 12 months, Biosynex SA has paid -2.56M in taxes.

Biosynex SA EV to EBITDA ratio is -13.25, with an EV/FCF ratio of -2.74.

Biosynex SA has €10.74M in cash and marketable securities with €63.03M in debt, giving a net cash position of €52.29M billion.

Gross margin is -19.76%, with operating margin of -40.23%, and net profit margin of -39.74%.

The average price target for Biosynex SA is ―, which is 11.43% higher than the current price. The consensus rating is ―